Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Active Psoriatic Arthritis
NCT01009086Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2009
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 3 trial of ustekinumab in psoriatic arthritis (PsA), sponsored by Janssen Pharmaceutical. Started Dec 2009; status: completed.
02
Drugs
ustekinumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01009086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009086.